Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia

Kim Jones, Terri Gelbart, Thomas C. Whisenant, Jill Waalen, Tony S. Mondala, David N. Iklé, Daniel R. Salomon, Robert (Rob) Bennett, Sunil M. Kurian

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Objective. Fibromyalgia (FM) is a common pain disorder characterised by nociceptive dysregulation. The basic biology of FM is poorly understood. Herein we have used agnostic gene expression as a potential probe for informing its underlying biology and the development of a proof-of-concept diagnostic gene expression signature. Methods. We analysed RNA expression in 70 FM patients and 70 healthy controls. The isolated RNA was amplified and hybridised to Affymetrix® Human Gene 1.1 ST Peg arrays. The data was analysed using Partek Genomics Suite v. 6.6. Results. Fibromyalgia patients exhibited a differential expression of 421 genes (p<0.001), several relevant to pathways for pain processing, such as glutamine/glutamate signaling and axonal development. There was also an upregulation of several inflammatory pathways and downregulation of pathways related to hypersensitivity and allergy. Using rigorous diagnostic modeling strategies, we show "locked" gene signatures discovered on Training and Test cohorts, that have a mean Area Under the Curve (AUC) of 0.81 on randomised, independent external data cohorts. Lastly, we identified a subset of 10 probesets that provided a diagnostic sensitivity for FM of 95% and a specificity of 96%. We also show that the signatures for FM were very specific to FM rather than common FM comorbidities. Conclusion. These findings provide new insights relevant to the pathogenesis of FM, and provide several testable hypotheses that warrant further exploration and also establish the foundation for a first blood-based molecular signature in FM that needs to be validated in larger cohorts of patients.

    Original languageEnglish (US)
    Pages (from-to)89-98
    Number of pages10
    JournalClinical and Experimental Rheumatology
    Volume34
    StatePublished - 2016

    Fingerprint

    Fibromyalgia
    Genome
    Hypersensitivity
    RNA
    Gene Expression
    Somatoform Disorders
    Genomics
    Glutamine
    Transcriptome
    Genes
    Area Under Curve
    Comorbidity
    Glutamic Acid
    Up-Regulation
    Down-Regulation
    Pain

    Keywords

    • Diagnostic signature
    • Fibromyalgia
    • Gene expression
    • Pathophysiology
    • Phenotype

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Jones, K., Gelbart, T., Whisenant, T. C., Waalen, J., Mondala, T. S., Iklé, D. N., ... Kurian, S. M. (2016). Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clinical and Experimental Rheumatology, 34, 89-98.

    Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. / Jones, Kim; Gelbart, Terri; Whisenant, Thomas C.; Waalen, Jill; Mondala, Tony S.; Iklé, David N.; Salomon, Daniel R.; Bennett, Robert (Rob); Kurian, Sunil M.

    In: Clinical and Experimental Rheumatology, Vol. 34, 2016, p. 89-98.

    Research output: Contribution to journalArticle

    Jones, K, Gelbart, T, Whisenant, TC, Waalen, J, Mondala, TS, Iklé, DN, Salomon, DR, Bennett, RR & Kurian, SM 2016, 'Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia', Clinical and Experimental Rheumatology, vol. 34, pp. 89-98.
    Jones K, Gelbart T, Whisenant TC, Waalen J, Mondala TS, Iklé DN et al. Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. Clinical and Experimental Rheumatology. 2016;34:89-98.
    Jones, Kim ; Gelbart, Terri ; Whisenant, Thomas C. ; Waalen, Jill ; Mondala, Tony S. ; Iklé, David N. ; Salomon, Daniel R. ; Bennett, Robert (Rob) ; Kurian, Sunil M. / Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia. In: Clinical and Experimental Rheumatology. 2016 ; Vol. 34. pp. 89-98.
    @article{8702da8978104a6c8c04e469c850b8fe,
    title = "Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia",
    abstract = "Objective. Fibromyalgia (FM) is a common pain disorder characterised by nociceptive dysregulation. The basic biology of FM is poorly understood. Herein we have used agnostic gene expression as a potential probe for informing its underlying biology and the development of a proof-of-concept diagnostic gene expression signature. Methods. We analysed RNA expression in 70 FM patients and 70 healthy controls. The isolated RNA was amplified and hybridised to Affymetrix{\circledR} Human Gene 1.1 ST Peg arrays. The data was analysed using Partek Genomics Suite v. 6.6. Results. Fibromyalgia patients exhibited a differential expression of 421 genes (p<0.001), several relevant to pathways for pain processing, such as glutamine/glutamate signaling and axonal development. There was also an upregulation of several inflammatory pathways and downregulation of pathways related to hypersensitivity and allergy. Using rigorous diagnostic modeling strategies, we show {"}locked{"} gene signatures discovered on Training and Test cohorts, that have a mean Area Under the Curve (AUC) of 0.81 on randomised, independent external data cohorts. Lastly, we identified a subset of 10 probesets that provided a diagnostic sensitivity for FM of 95{\%} and a specificity of 96{\%}. We also show that the signatures for FM were very specific to FM rather than common FM comorbidities. Conclusion. These findings provide new insights relevant to the pathogenesis of FM, and provide several testable hypotheses that warrant further exploration and also establish the foundation for a first blood-based molecular signature in FM that needs to be validated in larger cohorts of patients.",
    keywords = "Diagnostic signature, Fibromyalgia, Gene expression, Pathophysiology, Phenotype",
    author = "Kim Jones and Terri Gelbart and Whisenant, {Thomas C.} and Jill Waalen and Mondala, {Tony S.} and Ikl{\'e}, {David N.} and Salomon, {Daniel R.} and Bennett, {Robert (Rob)} and Kurian, {Sunil M.}",
    year = "2016",
    language = "English (US)",
    volume = "34",
    pages = "89--98",
    journal = "Clinical and Experimental Rheumatology",
    issn = "0392-856X",
    publisher = "Clinical and Experimental Rheumatology S.A.S.",

    }

    TY - JOUR

    T1 - Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia

    AU - Jones, Kim

    AU - Gelbart, Terri

    AU - Whisenant, Thomas C.

    AU - Waalen, Jill

    AU - Mondala, Tony S.

    AU - Iklé, David N.

    AU - Salomon, Daniel R.

    AU - Bennett, Robert (Rob)

    AU - Kurian, Sunil M.

    PY - 2016

    Y1 - 2016

    N2 - Objective. Fibromyalgia (FM) is a common pain disorder characterised by nociceptive dysregulation. The basic biology of FM is poorly understood. Herein we have used agnostic gene expression as a potential probe for informing its underlying biology and the development of a proof-of-concept diagnostic gene expression signature. Methods. We analysed RNA expression in 70 FM patients and 70 healthy controls. The isolated RNA was amplified and hybridised to Affymetrix® Human Gene 1.1 ST Peg arrays. The data was analysed using Partek Genomics Suite v. 6.6. Results. Fibromyalgia patients exhibited a differential expression of 421 genes (p<0.001), several relevant to pathways for pain processing, such as glutamine/glutamate signaling and axonal development. There was also an upregulation of several inflammatory pathways and downregulation of pathways related to hypersensitivity and allergy. Using rigorous diagnostic modeling strategies, we show "locked" gene signatures discovered on Training and Test cohorts, that have a mean Area Under the Curve (AUC) of 0.81 on randomised, independent external data cohorts. Lastly, we identified a subset of 10 probesets that provided a diagnostic sensitivity for FM of 95% and a specificity of 96%. We also show that the signatures for FM were very specific to FM rather than common FM comorbidities. Conclusion. These findings provide new insights relevant to the pathogenesis of FM, and provide several testable hypotheses that warrant further exploration and also establish the foundation for a first blood-based molecular signature in FM that needs to be validated in larger cohorts of patients.

    AB - Objective. Fibromyalgia (FM) is a common pain disorder characterised by nociceptive dysregulation. The basic biology of FM is poorly understood. Herein we have used agnostic gene expression as a potential probe for informing its underlying biology and the development of a proof-of-concept diagnostic gene expression signature. Methods. We analysed RNA expression in 70 FM patients and 70 healthy controls. The isolated RNA was amplified and hybridised to Affymetrix® Human Gene 1.1 ST Peg arrays. The data was analysed using Partek Genomics Suite v. 6.6. Results. Fibromyalgia patients exhibited a differential expression of 421 genes (p<0.001), several relevant to pathways for pain processing, such as glutamine/glutamate signaling and axonal development. There was also an upregulation of several inflammatory pathways and downregulation of pathways related to hypersensitivity and allergy. Using rigorous diagnostic modeling strategies, we show "locked" gene signatures discovered on Training and Test cohorts, that have a mean Area Under the Curve (AUC) of 0.81 on randomised, independent external data cohorts. Lastly, we identified a subset of 10 probesets that provided a diagnostic sensitivity for FM of 95% and a specificity of 96%. We also show that the signatures for FM were very specific to FM rather than common FM comorbidities. Conclusion. These findings provide new insights relevant to the pathogenesis of FM, and provide several testable hypotheses that warrant further exploration and also establish the foundation for a first blood-based molecular signature in FM that needs to be validated in larger cohorts of patients.

    KW - Diagnostic signature

    KW - Fibromyalgia

    KW - Gene expression

    KW - Pathophysiology

    KW - Phenotype

    UR - http://www.scopus.com/inward/record.url?scp=84984783314&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84984783314&partnerID=8YFLogxK

    M3 - Article

    VL - 34

    SP - 89

    EP - 98

    JO - Clinical and Experimental Rheumatology

    JF - Clinical and Experimental Rheumatology

    SN - 0392-856X

    ER -